Renal infection with Mycobacterium chelonei. 1980

G J Becker, and R G Walker, and L J Dziukas, and K J Harvey, and R Valentine, and P Kincaid-Smith

A case of renal infection with Mycobacterium chelonei is described. The infection probably occurred via haematogenous spread from an infected arteriovenous shunt in a uraemic woman. Prolonged treatment with intravenous cefoxitin combined with oral erythromycin and rifampicin eradicated the organism from the urine. Although renal function stabilised for one year, gradual deterioration to end-stage renal failure occurred.

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D009164 Mycobacterium Infections Infections with bacteria of the genus MYCOBACTERIUM. Infections, Mycobacterium,Infection, Mycobacterium,Mycobacterium Infection
D009165 Mycobacterium Infections, Nontuberculous Infections with nontuberculous mycobacteria (atypical mycobacteria): M. kansasii, M. marinum, M. scrofulaceum, M. flavescens, M. gordonae, M. obuense, M. gilvum, M. duvali, M. szulgai, M. intracellulare (see MYCOBACTERIUM AVIUM COMPLEX;), M. xenopi (littorale), M. ulcerans, M. buruli, M. terrae, M. fortuitum (minetti, giae), M. chelonae, M. leprae. Mycobacterium Infections, Atypical,Atypical Mycobacterial Infection, Disseminated,Atypical Mycobacterial Infection, Familial Disseminated,Atypical Mycobacteriosis, Familial,Atypical Mycobacteriosis, Familial Disseminated,Atypical Mycobacterium Infections,Infections, Atypical Mycobacterium,Mycobacterium abscessus Infection,Atypical Mycobacterium Infection,Familial Atypical Mycobacterioses,Familial Atypical Mycobacteriosis,Infection, Mycobacterium abscessus,Infections, Mycobacterium abscessus,Mycobacterioses, Familial Atypical,Mycobacteriosis, Familial Atypical,Mycobacterium Infection, Atypical,Mycobacterium Infection, Nontuberculous,Mycobacterium abscessus Infections,Nontuberculous Mycobacterium Infection,Nontuberculous Mycobacterium Infections
D002440 Cefoxitin A semisynthetic cephamycin antibiotic resistant to beta-lactamase. Cefoxitin Sodium,MK-306,Mefoxin,Mefoxitin,Méfoxin,MK 306,MK306,Sodium, Cefoxitin
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin

Related Publications

G J Becker, and R G Walker, and L J Dziukas, and K J Harvey, and R Valentine, and P Kincaid-Smith
February 1986, British medical journal (Clinical research ed.),
G J Becker, and R G Walker, and L J Dziukas, and K J Harvey, and R Valentine, and P Kincaid-Smith
March 1984, Tubercle,
G J Becker, and R G Walker, and L J Dziukas, and K J Harvey, and R Valentine, and P Kincaid-Smith
May 1974, Nihon Kyobu Shikkan Gakkai zasshi,
G J Becker, and R G Walker, and L J Dziukas, and K J Harvey, and R Valentine, and P Kincaid-Smith
November 1992, Southern medical journal,
G J Becker, and R G Walker, and L J Dziukas, and K J Harvey, and R Valentine, and P Kincaid-Smith
January 1990, The Australasian journal of dermatology,
G J Becker, and R G Walker, and L J Dziukas, and K J Harvey, and R Valentine, and P Kincaid-Smith
September 1983, American journal of kidney diseases : the official journal of the National Kidney Foundation,
G J Becker, and R G Walker, and L J Dziukas, and K J Harvey, and R Valentine, and P Kincaid-Smith
December 1981, Tubercle,
G J Becker, and R G Walker, and L J Dziukas, and K J Harvey, and R Valentine, and P Kincaid-Smith
October 1981, New York state journal of medicine,
G J Becker, and R G Walker, and L J Dziukas, and K J Harvey, and R Valentine, and P Kincaid-Smith
July 1984, Alabama medicine : journal of the Medical Association of the State of Alabama,
G J Becker, and R G Walker, and L J Dziukas, and K J Harvey, and R Valentine, and P Kincaid-Smith
January 1980, Dermatologica,
Copied contents to your clipboard!